Type 2 Cytokine-Dependent Skin Barrier Regulation in Personalized 2D and 3D Skin Models of Atopic Dermatitis: A Pilot Study
August 2024
in “
JID Innovations
”
TLDR AD-derived keratinocytes effectively mimic inflammation in atopic dermatitis.
This pilot study explored the effects of type 2 cytokines IL-4 and IL-13 on atopic dermatitis (AD) using personalized 2D and 3D skin models derived from keratinocytes (KCs) of AD patients. The study found that these cytokines, especially IL-13, significantly altered the expression of AD-associated genes and proteins, impacting skin barrier function. IL-13 alone induced spongiosis-like structures, a hallmark of AD, suggesting its dominant role in AD pathogenesis. The research supports using these in vitro models to study AD mechanisms and optimize treatments, highlighting IL-13 as a potential therapeutic target.